Putting the award page together from the records…
Putting the award page together from the records…
US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
Up for re-bid: ends 2027-01-13. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
35 actions since 2023-04-24. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-29 | P00039 | Change order definitized | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE CLIN POP AND PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00020 FROM SEPTEMBER 29, 2026 TO NOVEMBER 29, 2026. |
| 2026-09-02 | P00038 | Change order | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00022 FROM SEPTEMBER 3, 2026 TO NOVEMBER 3, 2026. |
| 2026-08-24 | P00037 | Change order | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00020 FROM AUGUST 25, 2026 TO SEPTEMBER 29, 2026. |
| 2026-07-02 | P00036 | Change order definitized | $0 | THE PURPOSE OF THIS MODIFICATION IS TO THE EXTEND THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00022 FROM JULY 3, 2026 TO SEPTEMBER 3, 2026. |
| 2026-06-30 | P00035 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE END DATE OF CLIN 0005 AT NO ADDITIONAL COST TO THE GOVERNMENT |
| 2026-06-24 | P00034 | Change order definitized | $0 | THE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00020 FROM JUNE 25, 2026 TO AUGUST 25, 2026 |
| 2026-05-15 | P00033 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE POP FOR CLINS 8, 9, AND 11 AT NO ADDITIONAL COST THE GOVERNMENT. |
| 2026-04-30 | P00032 | Change order definitized | $0 | THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0022 FROM MAY 3, 2026 TO JULY 3, 2026 |
| 2026-04-24 | P00031 | Change order definitized |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
| $0 |
| THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0020 FROM APRIL 25, 2026 TO JUNE 25, 2026 |
| 2026-03-03 | P00030 | Change order definitized | $0 | THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0022 FROM MARCH 3, 2026 TO MAY 3, 2026 |
| 2026-02-19 | P00029 | Change order definitized | $0 | THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0025 FROM FEB 25, 2026 TO APRIL 25, 2026 |
| 2026-01-30 | P00028 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS ACTION IS TO EXTEND CLIN 0008 AT NO ADDITIONAL COST TO THE GOVERNMENT |
| 2026-01-26 | P00027 | Option exercised | $53.90M | THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE |
| 2026-01-26 | P00026 | Change order | $26.37M | THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE |
| 2026-01-05 | P00025 | Administrative change | $0 | THE PURPOSE OF MODIFICATION P00020 IS TO EXERCISE OPTION CLIN 0010 AND INCORPORATE CHANGES TO THE DESCRIPTION OF SERVICES FOR DOMESTIC PRODUCIBILITY OF ESSENTIAL MEDICINES. |
| 2025-12-12 | P00024 | Administrative change | $0 | COR CHANGE |
| 2025-12-01 | P00023 | Supplemental agreement (work within scope) | $0 | ADD CLAUSE FAR 52.232-16 PROGRESS PAYMENTS (NOV 2021) ALTERNATE I (MAR 2000) |
| 2025-11-04 | P00022 | Change order | $25.00M | REVISE THE SCOPE OF EFFORT |
| 2025-10-23 | P00021 | Administrative change | $0 | UPDATE POC INFORMATION |
| 2025-09-30 | P00020 | Change order | $8.37M | THE PURPOSE OF MODIFICATION P00020 IS TO EXERCISE OPTION CLIN 0010 AND INCORPORATE CHANGES TO THE DESCRIPTION OF SERVICES FOR DOMESTIC PRODUCIBILITY OF ESSENTIAL MEDICINES. |
| 2025-08-27 | P00019 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF MODIFICATION P00019 IS TO EXTEND THE CLINS 0003, 0005, 0007, 0008 AT NO ADDITIONAL COST TO THE GOVERNMENT. |
| 2025-07-22 | P00018 | Administrative change | $0 | THE PURPOSE OF THIS MOD IS TO UPDATE THE CO FROM ROGER HERNANDEZ TO KIMBERLY GOLDEN |
| 2025-04-30 | P00017 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE BASE PERIOD (CLIN 0003 AND CLIN 0005) AT NO ADDITIONAL COST TO THE GOVERNMENT, UPDATE LANGUAGE IN #4 AND ADD ADDITIONAL MILESTONES IN MILESTONE DELIVERY SCHEDULE, TABLE F.4. PHLOW CORP. - U.S.-BASE |
| 2024-12-31 | P00016 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO ISSUE AN EXTENSION. |
| 2024-09-30 | P00015 | Supplemental agreement (work within scope) | $7.10M | CLIN 0005 SHALL BE INCREASED FROM $334,423,625.23 BY OBLIGATING $7,095,891.76 TO A CLIN VALUE OF $341,519,516.99. |
| 2024-09-29 | P00014 | Supplemental agreement (work within scope) | $3.89M | CLIN 0024 SHALL BE INCREASED FROM $0 BY OBLIGATING $3,892,431.86 TO A CLIN VALUE OF $3,892,431.86. |
| 2024-09-18 | P00013 | Option exercised | $52.27M | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 2 FOR CLIN 0009 AND CLIN 0010 AT FULL VALUE. |
| 2024-09-11 | P00012 | Supplemental agreement (work within scope) | $9.92M | THE PURPOSE OF THIS MODIFICATION IS TO ISSUE AN EXTENSION TO THE BASE PERIOD AND OPTION PERIOD 1, INCREMENTAL FUNDING AND ADDING COST OVERRUN ITEM OF G&A ON DIRECT LABOR. |
| 2024-08-28 | P00011 | Supplemental agreement (work within scope) | $7.73M | ADD $7,730,713.39 TO THE TOTAL CONTRACT VALUE: $4,033,088.15 WILL BE ADDED TO CLIN 0003 (U.S.- BASED PRODUCTION OF ACTIVE PHARMACEUTICAL INGREDIENTS (API) FOR COVID 19 MCMS/E |
| 2024-07-03 | P00010 | Option exercised | $10.21M | 1. CHANGE THE PERIOD OF PERFORMANCE FOR OPTION PERIOD 1 AT CLIN 0007 FROM 05/18/2024 THROUGH 05/17/2025 TO 07/03/2024 THROUGH 07/02/2025. 2. EXERCISE CLIN 0007 OPTION PERIOD 1 AT THE FULL VALUE OF $19,897,589.16 AND PROVIDE |
| 2024-06-12 | P00009 | Supplemental agreement (work within scope) | $0 | 1. CHANGE THE CONTRACTOR ADDRESS. AS A RESULT OF THIS MODIFICATION, BLOCK 8 OF THE SF30 REFLECTS THE UPDATED ADDRESS OF 424 HULL STREET, SUITE 400, RICHMOND, VA 232224-4114. BLOCK 7 OF THE SF26 AWARD DOCUMENT IS HEREBY UPDATED AS W |
| 2023-09-26 | P00008 | Supplemental agreement (work within scope) | $50.65M | THE PURPOSE OF MODIFICATION P00008 IS TO: 1. EXTEND THE BASE PERIOD OF PERFORMANCE AT CLINS 0001, 0003, 0004, AND 0005, AT NO ADDITIONAL COST TO THE GOVERNMENT; 2. UPDATE AND CHANGE THE TITLE DESCRIPTIONS OF ALL OPTION PERIOD CLINS, CLINS 0006 THRO |
| 2023-06-30 | P00007 | Administrative change | $0 | THE PURPOSE OF MODIFICATION P00007 IS TO ACCEPT THE TRANSFER OF CONTRACT ADMINISTRATION FROM ASPR/BARDA/PCI TO ASPR/IBMSC, AND TO MAKE ADMINISTRATIVE CHANGES TO SECTION G. |
| 2023-06-28 | P00006 | Administrative change | $0 | THE PURPOSE OF THIS MODIFICATION IS TO TRANSFER THE CONTRACT FROM ASPR/BARDA/PCI TO ASPR/IBMSC. |
| 2023-04-24 | P00005 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO REVISE THE CONTRACT STATEMENT OF OBJECTIVES (SOO) AND TABLE C.1 OF SECTION C.3 STATEMENT OF OBJECTIVES. |